Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease

被引：51
作者：
Dhanak, D
Keenan, RM
Burton, G
Kaura, A
Darcy, MG
Shah, DH
Ridgers, LH
Breen, A
Lavery, P
Tew, DG
West, A
机构：
[1] SmithKline Beecham Pharmaceut, Collegeville, PA 19426 USA
[2] SmithKline Beecham Pharmaceut, Harlow CM19 5AG, Essex, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 24期
关键词：
D O I：
10.1016/S0960-894X(98)00666-0
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A novel class of CMV protease inhibitors based on a benzothiopyran-S,S-dioxide nucleus has been discovered. Enzyme kinetic data supports a reversible mode of inhibition for a representative member of this class, 2-(3-pyridyl-N-oxide)benzothiopyran-4-one-S,S-dioxide, 1. Experiments in the presence and absence of the disulfide reducing agent DTT suggest that the inhibition by 1 is not due to oxidative inactivation of the enzyme. Also presented are results of some SAR studies of the benzothiopyranone ring system. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：3677 / 3682
页数：6
相关论文
共 50 条
[21]   Manipulation of CXCR4 signaling by human cytomegalovirus (HCMV) interleukin-10 [J].
Spencer, Juliet ;
Tu, Carolyn .
JOURNAL OF IMMUNOLOGY, 2018, 200 (01)
[22]   Synthesis and antiviral activity of monobactam derivatives as inhibitors of human cytomegalovirus protease. [J].
Naud, J ;
Ogilvie, WW ;
Yoakim, C ;
Dô, F ;
Haché, BC ;
Lagace, L ;
O'Meara, JA ;
Déziel, R .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 :U1210-U1210
[23]   Design and synthesis of new potent human cytomegalovirus (HCMV) inhibitors based on internally hydrogen-bonded 1,6-naphthyridines [J].
Chan, L ;
Stefanac, T ;
Lavallée, JF ;
Jin, HL ;
Bédard, J ;
May, S ;
Falardeau, G .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (02) :103-105
[24]   Design and synthesis of a potent macrocyclic 1,6-napthyridine anti-human cytomegalovirus (HCMV) inhibitors [J].
Falardeau, G ;
Lachance, H ;
St-Pierre, A ;
Yannopoulos, CG ;
Drouin, M ;
Bédard, J ;
Chan, L .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (06) :1693-1695
[25]   Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format [J].
Cottier, V ;
Barberis, A ;
Lüthi, U .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) :565-571
[26]   Human Cytomegalovirus (HCMV)-Specific CD4+ T Cells Are Polyfunctional and Can Respond to HCMV-Infected Dendritic Cells In Vitro [J].
Jackson, Sarah E. ;
Sedikides, George X. ;
Mason, Gavin M. ;
Okecha, Georgina ;
Wills, Mark R. .
JOURNAL OF VIROLOGY, 2017, 91 (06)
[27]   Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART [J].
Tamarit, A ;
Alberola, J ;
Mir, A ;
Benet, I ;
Mira, JV ;
Muñoz, C ;
Galindo, MJ ;
Navarro, D .
JOURNAL OF CLINICAL VIROLOGY, 2004, 29 (04) :308-314
[28]   Virtual screening of HIV-1 protease inhibitors against human cytomegalovirus protease using docking and molecular dynamics [J].
Jenwitheesuk, E ;
Samudrala, R .
AIDS, 2005, 19 (05) :529-531
[29]   Crystal structures of reversible ketone-based inhibitors of the cysteine protease cruzain [J].
Huang, L ;
Brinen, LS ;
Ellman, JA .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (01) :21-29
[30]   A new family of non-nucleoside inhibitors of human cytomegalovirus (HCMV) and varicella-zoster virus (VZV) based on the β-keto-γ-sultone template [J].
De Castro, S ;
García-Aparicio, C ;
Andrei, G ;
Snoeck, R ;
De Clercq, E ;
Balzarini, J ;
Camarasa, MJ ;
Velazquez, S .
ANTIVIRAL RESEARCH, 2005, 65 (03) :A74-A74
12345